Adolescent problem gambling: Neurodevelopment and pharmacological treatment

Gambling Problems in Youth: Theoretical and Applied Perspectives

Volumn , Issue , 2005, Pages 81-98

  Grant, Jon E ^a   Chambers, R Andrew ^b   Potenza, Marc N ^a  

^a BROWN UNIVERSITY   (United States)

^b Laboratory for Translational Neuroscience of Dual Diagnosis Disorders   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892289237     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-306-48586-9_5     Document Type: Chapter

References (77)

1. Abbott, A. (2003). British panel bans use of antidepressant to treat children. Nature, 423, 792.
2. Apter, A., Ratzoni, G., King, R. A., Weizman, A., Iancu, I., Binder, M., et al. (1994). Fluvoxamine open-label treatment of adolescent inpatients with obsessive-compulsive disorder or depression. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 342-348.
3. Armenteros, J. L. & Lewis, J. E. (2002). Citalopram treatment for impulsive aggression in children and adolescents: an open pilot study. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 522-529.
4. Baumgartner, J. L., Emslie, G. J., & Crismon, M. L. (2002). Citalopram in children and adolescents with depression or anxiety. Annals of Pharmacotherapy, 36, 1692-1697.
5. Bechara, A. (2003). Risky business: Emotion, decision-making, and addiction. Journal of Gambling Studies, 19, 23-51.
6. Blanco, C., Petkova, E., Ibanez, A., & Saiz-Ruiz, J. (2002). A pilot placebo-controlled study of fluvoxamine for pathological gambling. Annals of Clinical Psychiatry, 14, 9-15.
7. Campbell, M., Anderson, L. T., Small, A. M., Adams, P., Gonzalez, N. M., & Ernst, M. (1993). Naltrexone in autistic children: Behavioral symptoms and attentional learning. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 1283-1291.
8. Carroll, K. M. (1997) Integrating psychotherapy and pharmacotherapy to improve drug abuse treatment outcome. Addictive Behaviors, 22, 233-245.
9. Chambers, R. A. & Potenza, M. N. (2001). Schizophrenia and pathological gambling [Letter]. American Journal of Psychiatry, 158, 497-498.
10. Chambers, R. A. & Potenza, M. N. (2003). Neurodevelopment, impulsivity, and adolescent gambling. Journal of Gambling Studies, 19, 53-84.
11. Chambers, R. A., Taylor, J. R., & Potenza, M. N. (2003). Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. American Journal of Psychiatry, 160, 1041-1052.
12. Crockford, D. N. & el-Guebaly, N. (1998). Naltrexone in the treatment of pathological gambling and alcohol dependence. Canadian Journal of Psychiatry, 43, 86.
13. De la Gandara, J. J. (1999). Fluoxetine: Open-trial in pathological gambling Presented at the 152 Annual Meeting of the American Psychiatric Association; May 16-21; Washington, DC.
14. DelBello, M., Schwiers, M., Rosenberg, H., & Strakowski, S. (2002). Quetiapine as adjunctive treatment for adolescent mania associated with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1216-1223.
15. Derevensky, J. L, Gupta, R., & Winters, K. (2003). Prevalence rates of youth gambling problems: Are the current rates inflated? Journal of Gambling Studies, 19, 405-425.
16. DeVeaugh-Geiss, J., Moroz, G., Biederman, J., Cantwell, D., Fontaine, R., Greist, J. H., et al. (1992). Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder-a multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 45-49.
17. Driver-Dunkley, E., Samantra, J., & Stacy, M. (2003) Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology, 61, 422-423.
18. Emslie, G. J., Rush, A. J., Weinberg, W. A., Kowatch, R. A., Hughes, C. W., Carmody, T., et al. (1997). A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry, 54, 1031-1037.
19. Findling, R. L., Preskorn, S. H., Marcus, R. N., Magnus, R. D., D'Amico, F., Marathe, P., et al. (2000). Nefazodone pharmacokinetics in depressed children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 1008-1016.
20. Fiorillo, C. D., Tobler, P. N., & Schultz, W. (2003). Discrete coding of reward probability and uncertainty by dopamine neurons. Science, 299, 1898-1902.
21. Fisher, S. (2000). Developing the DSM-IV criteria to identify adolescent problem gambling in non-clinical populations. Journal of Gambling Studies, 16, 253-274.
22. Flament, M. F., Rapoport, J. L., Berg, C. J., Sceery, W., Kilts, C., Mellstrom, B., et al. (1985). Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlledstudy. Archives of General Psychiatry, 42, 977-983.
23. Frazier, J. A., Biederman, J., Tohen, M., Feldman, P. D., Jacobs, T. G., Toma, V., et al. (2001). A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 11, 239-250.
24. Geller, B., Cooper, T. B., Sun, K., Zimerman, B., Frazier, J., Williams, M., et al. (1998). Doubleblind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 171-178.
25. Geller, D. A., Hoog, S. L., Heiligenstein, J. H., Ricardi, R. K., Tamura, R., Kluszynski, S., et al. (2001). Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: A placebo-controlled clinical trial. Journal of the American Academy of Child andAdolescent Psychiatry, 40, 773-779.
26. Goodnick, P. J., Jorge, C. A., Hunter, T., & Kumar, A. M. (2000). Nefazodone treatment of adolescent depression: An open-label study of response and biochemistry. Annals of Clinical Psychiatry, 12, 97-100.
27. Grant, J. E. & Kim, S. W. (2002). Adolescent kleptomania treated with naltrexone: a case report. European Child & Adolescent Psychiatry, 11, 92-95.
28. Grant, J. E., Kim, S. W., & Potenza, M. N. (2003) Advances in the pharmacotherapy of pathological gambling disorder. Journal of Gambling Studies, 19, 85-109.
29. Grant, J. E., Kim, S. W., Potenza, M. N., Blanco, C., Ibanez, A., Stevens, L. C., et al. (2003). Paroxetine treatment of pathological gambling: a multi-center randomized controlled trial. International Clinical Psychopharmacology, 18, 243-249.
30. Gupta, R. & Derevensky, J. L. (1998). Adolescent gambling behavior: A prevalence study and examination of the correlates associated with problem gambling. Journal of Gambling Studies, 14, 319-345.
31. Haller, R. & Hinterhuber, H. (1994). Treatment of pathological gambling with carbamazepine. Pharmacopsychiatry, 27, 129.
32. Hollander, E., Frenkel, M., DeCaria, C., Trungold, S., & Stein, D. J. (1992). Treatment of pathological gambling with clomipramine. American Journal of Psychiatry, 149, 710-711.
33. Hollander, E., DeCaria, C. M., Mari, E., Wong, C. M., Mosovich, S., Grossman, R., et al. (1998). Short-term single-blind fluvoxamine treatment of pathological gambling. American Journal of Psychiatry, 155, 1781-1783.
34. Hollander, E., DeCaria, C. M., Finkell, J. N., Begaz, T., Wong, C. M., & Cartwright, C. (2000). A randomized double-blind fluvoxamine/placebo crossover trial in pathological gambling. Biological Psychiatry, 47, 813-817.
35. Hollander, E., Pallanti, S., & Baldini-Rossi, N. (2002). Sustained release lithium/placebo treatment response in bipolar spectrum pathological gamblers. Poster presented at the 42nd Annual New Clinical Drug Evaluation Unit Meeting, Boca Raton, Florida.
36. Kalivas, P. W., Churchill, L., & Romanides, A. (1999). Involvement of the palladal-thalamocortical circuit in adaptive behavior. Annals of the New York Academy of Sciences, 877, 64-70.
37. Keller, M. B., Ryan, N. D., Strober, M., Klein, R. G., Kutcher, S. P., Birmaher, B., et al. (2001). Efficacy of paroxetine in the treatment of adolescent major depression: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 762-772.
38. Kim, S. W. & Grant, J. E. (2001). An open naltrexone treatment study of pathological gambling disorder. International Clinical Psychopharmacology, 16, 285-289.
39. Kim, S. W., Grant, J. E., Adson, D. E., & Shin, Y. C. (2001). Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biological Psychiatry, 49, 914-921.
40. Kim, S. W., Grant, J. E., Adson, D. E., Shin, Y. C., & Zaninelli, R. M. (2002). A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. Journal of Clinical Psychiatry, 63, 501-507.
41. Kolmen, B. K., Feldman, H. M., Handen, B. L., & Janosky, J. E. (1995). Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 223-231.
42. Kowatch, R. A., Suppes, T., Carmody, T. J., Bucci, J. P., Hume, J. H., Kromelis, M., et al. (2000). Effect size of lithium, divalproex sodium and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 713-720.
43. Leonard, H. L., Swedo, S. E., Rapoport, J. L., Koby, E. V., Lenane, M. C., Cheslow, D. L., et al. (1989). Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison. Archives of General Psychiatry, 46, 1088-1092.
44. Lewis. D. A. (1997). Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia. Neuropsychopharmacology, 16, 385-398.
45. Lifrak, P. D., Alterman, A. I., O'Brien, C. P., & Volpicelli, J. R. (1997). Naltrexone for alcoholic adolescents. American Journal of Psychiatry, 154, 439-141.
46. Moskowitz, J. A. (1980). Lithium and lady luck: use of lithium carbonate in compulsive gambling. New York State Journal of Medicine, 80, 785-788.
47. New, A. S., Hazlett, E. A., Buchsbaum, M. S., Goodman, M., Reynolds, D., Mitropoulou, V., et al. (2002). Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Archives of General Psychiatry, 59, 621-629.
48. Pallanti, S., Baldini Rossi, N., Sood, E., & Hollander, E. (2002a). Nefazodone treatment of pathological gambling: A prospective open-label controlled trial. Journal of Clinical Psychiatry, 63, 1034-1039.
49. Pallanti, S., Quercioli, L., Sood, E., & Hollander, E. (2002b). Lithium and valproate treatment of pathological gambling: a randomized single-blind study. Journal of Clinical Psychiatry, 63, 559-564.
50. Papatheodorou, G., Kutcher, S. P., Katic, M., & Szalai, J. P. (1995). The efficacy and safety of divalproex sodium in the treatment of acute mania in adolescents and young adults: an open clinicaltrial. Journal of Clinical Psychopharmacology, 15, 110-116.
51. Petry, N. M. (2002). How treatments for pathological gambling can be informed by treatments for substance use disorders. Experimental and Clinical Psychopharmacology, 10, 180-192.
52. Physician's Desk Reference (57th ed. ). (2003). Montvale, NJ: Thompson PDR.
53. Potenza, M. N. (2002). A perspective on future directions in the prevention, treatment and research of pathological gambling. Psychiatric Annals, 32, 203-207.
54. Potenza, M. N., Fiellin, D. A., Heninger, G. R., Rounsaville, B. J., & Mazure, C. M. (2002). Gambling: An addictive behavior with health and primary care implications. Journal of General Internal Medicine, 17, 721-732.
55. Potenza, M. N., & Hollander, E. (2002). Pathological gambling and impulse control disorders. In J. T. Coyle, C. Nemeroff, D. Charney, & K. L. Davis (Eds. ), Neuropsycho-pharmacology: The 5th generation of progress. (pp. 1725-1741). Baltimore, MD: Lippincott Williams and Wilkins.
56. Potenza, M. N., & McDougle, C. J. (1998). The potential of atypical antipsychotics in the treatment of non-psychotic disorders. CNS Drugs, 9, 213-232.
57. Proimos, J., DuRant, R. H., Pierce, J. D., & Goodman, E. (1998). Gambling and other risk behaviors among 8th-to 12th-grade students. Journal of Pediatrics, 102, e23.
58. Riddle, M. A., Scahill, L., King, R. A., Hardin, M. T., Anderson, G. M., Ort, S. I., et al. (1992). Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 1062-1069.
59. Riddle, M. A., Reeve, E. A., Yaryura-Tobias, J. A., Yang, H. M., Claghorn, J. L., Gaffney, G., et al. (2001). Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 222-229.
60. Romer, D. (2003). Reducing adolescent risk: Toward an integrated approach. Sage Publications, Thousand Oaks, CA.
61. Rosenberg, D. R., Stewart, C. M., Fitzgerald, K. D., Tawile, V., & Carroll, E. (1999). Paroxetine open-label treatment of pediatric outpatients with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 1180-1185.
62. Rugle, L. (2000). The use of olanzapine in the treatment of video poker pathological gamblers [Abstract]. Presented at the conference entitled, "The Comorbidity of Pathological Gambling: A Current Research Synthesis"; December 3-5; Las Vegas, Nevada.
63. Shah, K. R., Eisen, S. A., Xian, H., & Potenza, M. N. (in press). Genetic studies of pathological gambling: A review of methodology and analyses of data from the Vietnam Era Twin (VET) Registry. Journal of Gambling Studies.
64. Slutske, W. S., Eisen, S., True, W. R., Lyons, M. J., Goldberg, J., & Tsuang, M. (2000). Common genetic vulnerability for pathological gambling and alcohol dependence in men. Archives of General Psychiatry, 57, 666-673.
65. Stigler, K. A., Potenza, M. N., & McDougle, C. J. (2001) Tolerability profile of atypical antipsychotics in children and adolescents. Pediatric Drugs, 3, 927-942.
66. Stigler, K. A., Potenza, M. N., Posey, D., & McDougle, C. J. (2004). Bodyweight gain associated with atypical antipsychotic use in children and adolescents: Epidemiology, clinical relevance and management. Pediatric Drugs, 6, 33-44.
67. Stinchfield, R. (2001). A comparison of gambling among Minnesota public school students in 1992, 1995 and 1998. Journal of Gambling Studies, 17, 273-296.
68. Stinchfield, R. (2003). Reliability, validity, and classification accuracy of a measure of DSM-IV diagnostic criteria for Pathological Gambling. American Journal of Psychiatry, 160, 180-182.
69. Thomsen, P. H. (1997). Child and adolescent obsessive-compulsive disorder treated with citalopram: findings from an open trial of 23 cases. Journal of Child and Adolescent Psychopharmacology, 7, 157-166.
70. Tsuang, M. T., Bar, J. L., Harley, R. M., & Lyons, M. J. (2001). The Harvard twin study of substance abuse: What we have learned. Harvard Review of Psychiatry, 9, 267-79.
71. Wagner, F. A. & Anthony, J. C. (2002). From first drug use to drug dependence: developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsycho-pharmacology, 26, 479-488.
72. Wagner, K. D., Weller, E. B., Carlson, G. A., Sachs, G., Biederman, J., Frazier, J. A., et al. (2002). An open-label trial of divalproex in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1224-1230.
73. Walkup, J., Labellarte, M., Riddle, M. A., Pine, D. S., Greenhill, L., Fairbanks, J., et al. (2002). Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study. Journal of Child and Adolescent Psychopharmacology, 12, 175-188.
74. Wallisch, L. (1993). Gambling in Texas: 1992 Texas survey of adolescent gambling behavior. Austin, TX: Texas Commission on Alcohol and Drug Abuse.
75. Winters, K. C., Stinchfield, R., & Fulkerson, J. (1993). Patterns and characteristics of adolescent gambling. Journal of Gambling Studies, 9, 371-386.
76. Wynne, H., Smith, G., & Jacobs, D. (1996). Adolescent gambling and problem gambling in Alberta. Edmonton, Alberta: Alberta Alcohol and Drug Abuse Commission.
77. Zimmerman, M., Breen, R. B., & Posternak, M. A. (2002). An open-label study of citalopram in the treatment of pathological gambling. Journal of Clinical Psychiatry, 63, 44-48.